745 related articles for article (PubMed ID: 25991472)
21. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
[TBL] [Abstract][Full Text] [Related]
22. Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.
Bozzano F; Costa P; Passalacqua G; Dodi F; Ravera S; Pagano G; Canonica GW; Moretta L; De Maria A
Int Immunol; 2009 Jul; 21(7):779-91. PubMed ID: 19461127
[TBL] [Abstract][Full Text] [Related]
23. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions.
Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q
Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
[TBL] [Abstract][Full Text] [Related]
25. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
Carson WE; Fehniger TA; Caligiuri MA
Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
[TBL] [Abstract][Full Text] [Related]
26. Age-related changes in natural killer cell receptors from childhood through old age.
Almeida-Oliveira A; Smith-Carvalho M; Porto LC; Cardoso-Oliveira J; Ribeiro Ados S; Falcão RR; Abdelhay E; Bouzas LF; Thuler LC; Ornellas MH; Diamond HR
Hum Immunol; 2011 Apr; 72(4):319-29. PubMed ID: 21262312
[TBL] [Abstract][Full Text] [Related]
27. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study.
Di Benedetto S; Derhovanessian E; Steinhagen-Thiessen E; Goldeck D; Müller L; Pawelec G
Biogerontology; 2015 Oct; 16(5):631-43. PubMed ID: 25732234
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Bogers WM; Boonstra A; Koopman G
Clin Exp Immunol; 2016 Jul; 185(1):42-9. PubMed ID: 26850369
[TBL] [Abstract][Full Text] [Related]
29. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.
Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D
Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859
[TBL] [Abstract][Full Text] [Related]
30. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
31. Increased CD56(bright) NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype.
Bhardwaj S; Ahmad F; Wedemeyer H; Cornberg M; Schulze Zur Wiesch J; van Lunzen J; Sarin SK; Schmidt RE; Meyer-Olson D
Virol J; 2016 Apr; 13():67. PubMed ID: 27091211
[TBL] [Abstract][Full Text] [Related]
32. Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.
Spallanzani RG; Torres NI; Avila DE; Ziblat A; Iraolagoitia XL; Rossi LE; Domaica CI; Fuertes MB; Rabinovich GA; Zwirner NW
J Immunol; 2015 Sep; 195(5):2141-8. PubMed ID: 26232426
[TBL] [Abstract][Full Text] [Related]
33. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells.
Hermann E; Alonso-Vega C; Berthe A; Truyens C; Flores A; Cordova M; Moretta L; Torrico F; Braud V; Carlier Y
Pediatr Res; 2006 Jul; 60(1):38-43. PubMed ID: 16690951
[TBL] [Abstract][Full Text] [Related]
34. Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C
Nerreter T; Zeiß S; Herrmann T; Einsele H; Seggewiss-Bernhardt R
Immunobiology; 2017 May; 222(5):719-725. PubMed ID: 28139257
[TBL] [Abstract][Full Text] [Related]
35. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
Romero AI; Thorén FB; Brune M; Hellstrand K
Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
[TBL] [Abstract][Full Text] [Related]
36. NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.
Martner A; Rydström A; Riise RE; Aurelius J; Brune M; Foà R; Hellstrand K; Thorén FB
Oncotarget; 2015 Dec; 6(40):42569-74. PubMed ID: 26544512
[TBL] [Abstract][Full Text] [Related]
37. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
38. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression.
Kim N; Yi E; Lee E; Park HJ; Kim HS
Front Immunol; 2024; 15():1388018. PubMed ID: 38698855
[TBL] [Abstract][Full Text] [Related]
40. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
